Xinting Sang

6.8k total citations · 1 hit paper
225 papers, 4.1k citations indexed

About

Xinting Sang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinting Sang has authored 225 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 86 papers in Surgery and 61 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinting Sang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (65 papers), Hepatocellular Carcinoma Treatment and Prognosis (49 papers) and Pancreatic and Hepatic Oncology Research (33 papers). Xinting Sang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (65 papers), Hepatocellular Carcinoma Treatment and Prognosis (49 papers) and Pancreatic and Hepatic Oncology Research (33 papers). Xinting Sang collaborates with scholars based in China, United States and United Kingdom. Xinting Sang's co-authors include Haitao Zhao, Xiaobo Yang, Yilei Mao, Jianzhen Lin, Huayu Yang, Shouxian Zhong, Xin Lu, Junyu Long, Yiyao Xu and Bo Hu and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Nature Communications.

In The Last Decade

Xinting Sang

215 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis

2023 92 citations Shitao Jiang, Y. Liu et al. International Journal of Surgery profile →

Peers

Countries citing papers authored by Xinting Sang

Since Specialization

Citations

This map shows the geographic impact of Xinting Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinting Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinting Sang more than expected).

Fields of papers citing papers by Xinting Sang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinting Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinting Sang. The network helps show where Xinting Sang may publish in the future.

Co-authorship network of co-authors of Xinting Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinting Sang. A scholar is included among the top collaborators of Xinting Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinting Sang. Xinting Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DMTNet: dual-domain adaptive multi-scale feature fusion network with transformer for small target detection 2025 ·The Visual Computer ·Yan Zhang, Xinting Sang, (unknown), (unknown), (unknown)	2
2	Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study 2024 ·Cancer Immunology Immunotherapy ·(unknown), Jiashuo Chao, Hao Wang, Shuofeng Li, Yunchao Wang, Chengpei Zhu, Nan Zhang, (unknown), Xu Yang, Kai Liu, Ziyu Xun, Xinting Sang, Xiaobo Yang, (unknown), Haitao Zhao	3
3	Multicellular 3D bioprinted human gallbladder carcinoma for in vitro mimicry of tumor microenvironment and intratumoral heterogeneity 2024 ·Biofabrication ·(unknown), Jiangang Zhang, (unknown), Yiran Li, Huiyu Yang, (unknown), (unknown), (unknown), Bao Jin, Pengyu Huang, Huayu Yang, Shunda Du, Xinting Sang, Yilei Mao	3
4	Safety and Perioperative Outcomes of Laparoscopic vs. Open Hepatectomy of Central-Located Liver Lesions: A Multicenter, Propensity Score-Matched, Retrospective Cohort Study 2023 ·Journal of Clinical Medicine ·Bao Jin, (unknown), (unknown), Gang Xu, Yuxin Wang, Yuke Zhang, Yitong Liu, (unknown), Xiao Liu, Xueshuai Wan, Huayu Yang, Xin Lü, Xinting Sang, Yilei Mao, Zhixian Hong, Shunda Du	0
5	Application and Progress of Cultured Models of Gallbladder Carcinoma 2023 ·Journal of Clinical and Translational Hepatology ·(unknown), Peiwen Ding, Xueshuai Wan, Gang Xu, Yilei Mao, Xinting Sang, Shunda Du, Huayu Yang	5
6	Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis breakdown → 2023 ·International Journal of Surgery ·Shitao Jiang, Y. Liu, Han Zheng, Lei Zhang, Haitao Zhao, Xinting Sang, Yiyao Xu, Xin Lu	92
7	Evolution of associating liver partition and portal vein ligation for staged hepatectomy from 2012 to 2021: A bibliometric analysis. Review 2022 ·International Journal of Surgery ·Junwei Zhang, Xiaobo Yang, (unknown), (unknown), (unknown), (unknown), Man Li, Jinglin Zhang, Lei Zhang, Haitao Zhao, Xinting Sang, Yiyao Xu, Weiguang Zhang, Xin Lü	5
8	A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery 2022 ·Scientific Reports ·Shitao Jiang, Junwei Zhang, Lei Zhang, Yiyao Xu, Haitao Zhao, Xinting Sang, Xin Lü	10
9	Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer 2021 ·Nature Communications ·Jianzhen Lin, Xinxin Peng, (unknown), Junyu Long, (unknown), Hongyue Li, Yi Bai, Xu Yang, Dongxu Wang, Xin Lü, Yilei Mao, Xinting Sang, (unknown), Haitao Zhao, Han Liang	22
10	Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients with Gallbladder Carcinoma 2020 ·SHILAP Revista de lepidopterología ·(unknown), Xiaoyan Wu, Xiang Wang, (unknown), Gelin Xu, Jianping Xiong, Jian Zhang, Xinting Sang, Yun Zheng, Liu W	1
11	<p>Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy</p> 2020 ·Cancer Management and Research ·(unknown), (unknown), Bao Jin, (unknown), Yue Shi, Haifeng Xu, Yongchang Zheng, (unknown), Shunda Du, Xin Lü, Xinting Sang, Yilei Mao	6
12	Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience 2020 ·SHILAP Revista de lepidopterología ·Lijiang Sun, Dawei Wang, Minming Zhang, Yongfeng Jin, (unknown), Xu H, Shunda Du, Xu Yang, Haitao Zhao, (unknown), Xinting Sang, (unknown), Huijuan Yang, Yan Mao	1
13	<p>Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients with Gallbladder Carcinoma</p> 2020 ·Cancer Management and Research ·Weiyu Xu, Xiaoqian Wu, Xuezhu Wang, Si Yu, Gang Xu, (unknown), (unknown), Xinting Sang, Yongchang Zheng, (unknown)	6
14	<p>Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center</p> 2020 ·Cancer Management and Research ·(unknown), (unknown), Bao Jin, Yue Shi, (unknown), Haifeng Xu, Yongchang Zheng, (unknown), Shunda Du, Xin Lü, Yilei Mao, Xinting Sang	2
15	Alterations in DNA Damage Repair Genes in Primary Liver Cancer 2019 ·Clinical Cancer Research ·Jianzhen Lin, Junping Shi, Honglin Guo, Xu Yang, Yan Jiang, Junyu Long, Yi Bai, Dongxu Wang, Xiaobo Yang, Xueshuai Wan, Lei Zhang, Jie Pan, Ke Hu, Mei Guan, Li Huo, Xinting Sang, Kai Wang, Haitao Zhao	80
16	GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer 2019 ·Analytical Cellular Pathology ·Yongchang Zheng, Yue Shi, Si Yu, Yuanyuan Han, Kai Kang, Haifeng Xu, (unknown), Xinting Sang, Yang Chen, (unknown)	30
17	Prognostic role of neutrophil-to-lymphocyte ratio in unresectable hepatocellular cancer patients treated with trans-arterial chemoembolization 2018 ·Translational Cancer Research ·Weiyu Xu, Jianping Xiong, Jianzhen Lin, Junyu Long, Yi Bai, Yongchang Zheng, Hongyu Xue, Xinting Sang, Haitao Zhao	2
18	Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma 2016 ·Journal of Clinical Gastroenterology ·Shunda Du, Gang Liu, Xinqi Cheng, Yue Li, Qian Wang, Ji Li, Xin Lü, Yongchang Zheng, Haifeng Xu, Tianyi Chi, Haitao Zhao, Yiyao Xu, Xinting Sang, Shouxian Zhong, (unknown)	14
19	Application of associating liver partition and portal vein ligation for staged hepatectomy(ALPPS) in cirrhotic patients with hepatocellular carcinoma 2016 ·Zhonghua putong waike zazhi ·Yiyao Xu, (unknown), Huayu Yang, Yilei Mao, Xinting Sang, Haitao Zhao, Haifeng Xu, Tianyi Chi, Shunda Du, Shouxian Zhong	1
20	Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma 2015 ·Medicine ·Wenjun Liao, (unknown), Penglei Ge, Huayu Yang, (unknown), Xin Lu, Xinting Sang, Shouxian Zhong	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact